NEJM
New England Journal of Medicine
NEJM
Clinician
NEJM
Evidence
NEJM
AI
NEJM
Catalyst
NEJM
Voices
Loading...
NEJM Research Summary
Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
New England Journal of Medicine
Nov 2
1 min read
New England Journal of Medicine
November 2
1 min read
New England Journal of Medicine
November 2
1 min read
Related Content
Original Article
Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
Journal Watch
Anticoagulation for Patients with Atrial Fibrillation and One Risk Factor
Topics
Cardiology
Anticoagulation/Thromboembolism (Cardiology)
Arrhythmias/Pacemakers/Defibrillators
Clinical Medicine
Hospital Medicine
Ambulatory Medicine